coumarin 6 and Liver Neoplasms
coumarin 6 has been researched along with Liver Neoplasms in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bao, X; Chu, QC; Gao, M; Guan, X; Jiang, N; Liu, KX; Tian, Y; Xu, H; Zhang, CH | 1 |
| Wei, MY; Wu, CB; Xu, YH; Zou, Q | 1 |
| Chu, Q; Deng, S; Gao, M; Guan, X; Huo, X; Liu, H; Liu, K; Ma, X; Tian, Y; Xu, H | 1 |
| Deng, L; Tang, C; Tu, L; Wei, M; Wu, C; Xu, T; Xu, Y; Zou, Q | 1 |
Other Studies
4 other study(ies) available for coumarin 6 and Liver Neoplasms
| Article | Year |
|---|---|
A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Coumarins; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Oleanolic Acid; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Thiazoles; Vitamin E | 2015 |
[In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].
Topics: Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Coumarins; Drug Delivery Systems; Endocytosis; Hep G2 Cells; Humans; Lactoferrin; Liposomes; Liver Neoplasms; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Thiazoles | 2015 |
Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Coumarins; Drug Carriers; Hep G2 Cells; Humans; Lactic Acid; Liver Neoplasms; Male; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Thiazoles; Vitamin E | 2016 |
Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Chemistry, Pharmaceutical; Coumarins; Hep G2 Cells; Humans; Lactoferrin; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; NIH 3T3 Cells; Polyethylene Glycols; Random Allocation; Thiazoles; Xenograft Model Antitumor Assays | 2012 |